NEW YORK, April 1, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Innoviz Technologies Ltd. (“Innoviz Technologies” or the “Company”) (NASDAQ: INVZ) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Innoviz…
Month: April 2024
NEW YORK, April 1, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in agilon health, inc. (“agilon health” or the “Company”) (NYSE: AGL) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of agilon health investors who were…
DUBLIN, April 1, 2024 /PRNewswire/ — The “Global Solar PV Growth Opportunities” report has been added to ResearchAndMarkets.com’s offering. This study assesses growth opportunities for the global solar PV market and uses proprietary modeling to estimate its revenue potential. The model…
NEW YORK, April 1, 2024 /PRNewswire/ — Levi & Korsinsky, LLP notifies investors in Innodata Inc. (“Innodata” or the “Company”) (NASDAQ: INOD) of a class action securities lawsuit. CLASS DEFINITION: The lawsuit seeks to recover losses on behalf of Innodata investors who were adversely…
The independent Data and Safety Monitoring Board (DSMB) recommended the continuation of patient enrollment as planned. There has been no safety concern with the use of Leuprolide (FP-001) injectable Emulsion in pediatric CPP patients. TAIPEI, April 1, 2024 /PRNewswire/ — Foresee…
HAIFA, Israel, April 1, 2024 /PRNewswire/ — On February 21, 2024, Elbit Systems Ltd. (NASDAQ: ESLT) (TASE: ESLT) (the “Company”) filed a Current Report on Form 6-K with the U.S. Securities and Exchange Commission and an equivalent report with the Tel Aviv Stock Exchange (the “Original…
PHILADELPHIA, April 1, 2024 /PRNewswire/ — ObservSMART, a leading proximity-based technology system for ensuring patient safety in healthcare settings, proudly announces the accomplishment of reaching 1 billion compliant observations. This significant milestone highlights the commitment…
NEW YORK , April 1, 2024 /PRNewswire/ — The Enzyme-Linked Immunosorbent Assay (ELISA) testing market is set for substantial expansion, with an estimated growth of USD 564.97 million between 2022 and 2027. This growth is attributed to various factors, including the increasing demand for…
NEW YORK, April 1, 2024 /PRNewswire/ — Attorney Advertising– Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Shoals Technologies Group, Inc. (“Shoals” or “the Company”) (NASDAQ: SHLS) and certain…
QIONGHAI, China, April 1, 2024 /PRNewswire/ — The Sub-forum on Religious Harmony and Mutual Learning Among Civilizations took place at the Boao Forum for Asia (BFA) Annual Conference 2024 by March 29. Nine religious representatives from China, Japan, South Korea, Vietnam, Nepal,…
